Lysodren
NDC 76336-080, mitotane, tablet, from HRA Pharma Rare Diseases.
- Product NDC
- 76336-080
- Status
- Listed
- Labeler
- HRA Pharma Rare Diseases
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA016885
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/76336-080 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- MITOTANE500 mg/1
Pharmacologic classes
Cytochrome P450 3A4 Inducers [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 76336-080-60 | 76336008060 | 1 BOTTLE in 1 CARTON (76336-080-60) / 100 TABLET in 1 BOTTLE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/f0cd76e9-460c-450e-b094-172e636f340a
Use it
Look up 76336-080 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/76336-080 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 76336-080. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.